Capricor Therapeutics, Inc.

CAPR ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Assets
Cash & Equivalents $6.1M $3.2M $5.6M $8.0M $1.7M $170.1K $1.6M $3.4M
Accounts Receivable — — — — — — — —
Inventory — — — — — — — —
Total Current Assets $15.7M $18.1M $14.0M $11.6M $3.7M $5.2M $1.3M $3.6M
Property, Plant & Equipment $372.1K $435.3K $318.6K $229.5K $74.2K $33.9K $9.7K $16.8K
Goodwill — — — — $1.9M — — —
Intangible Assets (Excl. Goodwill) $93.0K $142.3K $191.0K $239.8K $257.2K $178.3K — —
Total Assets $16.3M $18.7M $16.1M $13.6M $5.5M $5.4M $1.4M $3.7M
Liabilities
Accounts Payable — — — — — $182.9K $437.8K $332.4K
Total Current Liabilities $1.7M $4.9M $6.5M $6.3M $2.1M $529.2K $541.4K $1.1M
Long-Term Debt — — — — — — — —
Total Liabilities $5.0M $22.8M $17.1M $19.9M $6.1M $529.2K $541.4K $1.9M
Stockholders' Equity
Retained Earnings $-51.5M $-54.0M $-35.2M $-22.3M $-16.1M $-46.7M $-44.8M $-39.9M
Total Stockholders' Equity $11.2M $-4.0M $-1.0M $-6.2M $-534.9K $4.9M $1.7M $1.8M
← Newer Page 2 of 2 Older →